Ghayur Ayesha, Elahi Qurrat, Patel Chinmay, Raj Rishi
Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
Department of Family Medicine, Pikeville Medicine Center, Pikeville, Kentucky, USA.
Endocrinol Diabetes Metab Case Rep. 2021 Jun 1;2021. doi: 10.1530/EDM-21-0034.
Hypothyroidism is a common medical condition and is often easily managed with excellent outcomes, when treated adequately. Compliance with levothyroxine (LT4) therapy is often compromised because of the need for a daily and lasting schedule. Overt rhabdomyolysis due to under-treatment or non-compliance is a rare occurrence. We report a case of rhabdomyolysis leading to acute kidney injury (AKI) on chronic kidney disease (CKD) requiring hemodialysis (HD) in a 68-year-old Caucasian male due to non-compliance with levothyroxine (LT4) therapy. Our patient 'ran out of levothyroxine' for approximately 4 weeks and developed gradually progressive muscle pain. The diagnosis of severe AKI due to rhabdomyolysis was made based on oliguria, elevated creatinine kinase (CK), and renal failure. Resuming the home dose of LT4 failed to correct CK levels, and there was a progressive decline in renal function. Although increasing doses of LT4 and three cycles of HD improved CK levels, they remained above baseline at the time of discharge. The patient recovered gradually and required HD for 4 weeks. CK levels normalized at 6 weeks. Through this case report, we highlight that non-compliance with LT4 therapy can lead to life-threatening complications such as renal failure and hence the need to educate patients on the significance of compliance with LT4 therapy should be addressed.
Non-compliance to levothyroxine therapy is common and can lead to serious complications, including rhabdomyolysis. Rhabdomyolysis is an uncommon presentation of hypothyroidism and severe rhabdomyolysis can result in renal failure requiring hemodialysis. Rhabdomyolysis associated with hypothyroidism can be further exacerbated by concomitant use of statins.
甲状腺功能减退是一种常见的病症,若得到充分治疗,通常易于管理且预后良好。由于需要每日持续服药,左甲状腺素(LT4)治疗的依从性常常受到影响。因治疗不足或不依从导致的明显横纹肌溶解症较为罕见。我们报告一例68岁白人男性因不依从左甲状腺素(LT4)治疗,发生横纹肌溶解症并导致慢性肾脏病(CKD)合并急性肾损伤(AKI),需要进行血液透析(HD)。我们的患者左甲状腺素“用完”约4周,逐渐出现进行性肌肉疼痛。根据少尿、肌酸激酶(CK)升高和肾衰竭,诊断为横纹肌溶解症导致的严重AKI。恢复家庭剂量的LT4未能纠正CK水平,肾功能逐渐下降。尽管增加LT4剂量并进行三个周期的HD改善了CK水平,但出院时仍高于基线。患者逐渐康复,需要进行4周的HD。CK水平在6周时恢复正常。通过本病例报告,我们强调不依从LT4治疗可导致肾衰竭等危及生命的并发症,因此有必要对患者进行关于依从LT4治疗重要性的教育。
不依从左甲状腺素治疗很常见,可导致包括横纹肌溶解症在内的严重并发症。横纹肌溶解症是甲状腺功能减退症的一种罕见表现,严重的横纹肌溶解症可导致肾衰竭需要进行血液透析。同时使用他汀类药物可进一步加重与甲状腺功能减退症相关的横纹肌溶解症。